Sept. 11, 2019

Latest News

  • The uninsured rate is up for the first time in nearly a decade, Census data shows

    September 11, 2019 (11:30 AM)

    New data from the U.S. Census Bureau show the country's uninsured rate increased from 7.9% in 2017 to 8.5% in 2018, marking the first year-to-year increase reflected in Census data since 2008 to 2009, when the United States was at the highest point of the Great Recession.

  • Mayo Clinic + Google: The new 10-year plan to 'redefine how health care is delivered'

    September 11, 2019 (11:00 AM)

    Mayo Clinic on Tuesday announced a 10-year strategic partnership with Google to develop new artificial intelligence technologies—and their plan includes a new Google office located in Mayo's hometown of Rochester, Minnesota.

  • How does Pelosi want to lower Rx prices? Leaked bill offers clues.

    September 11, 2019 (10:30 AM)

    House Speaker Nancy Pelosi (D-Calif.) as early as this week could release a bill to tackle rising prescription drug costs—and a summary of the bill obtained by media outlets suggests Pelosi is considering allowing HHS to negotiate drug prices for certain treatments and establishing a drug price ceiling based on the prices paid for the drugs in other countries.

  • Groupon is now selling CT scans. Is that 'bonkers'?

    September 11, 2019 (10:00 AM)

    As the debate around health care prices continues, some providers are turning to Groupon to get new patients in the door with deals on health care services—a trend that has persisted despite the industry's efforts to move away from volume-driven care.

  • FDA warns Juul for marketing products as safer than traditional cigarettes

    September 11, 2019 (9:30 AM)

    FDA on Monday announced that it has warned e-cigarette maker Juul Labs for illegally marketing its nicotine pods as a less harmful alternative to traditional cigarettes, and for doing so in a presentation to youth at a U.S. school.

  • Novo Nordisk to launch lower-cost, generic insulin in US

    September 11, 2019 (9:00 AM)

    Novo Nordisk on Friday announced that it will offer generic versions of its insulin drug Novolog at 50% of the drug's current list price in the United States, making it the last of the so-called "Big Three" insulin drugmakers to offer lower-cost insulin products to U.S. consumers.

  • Where EMS providers take patients might depend on race, study suggests

    September 11, 2019 (8:30 AM)

    Black and Hispanic Medicare beneficiaries are less likely to be transported to the same emergency departments as white Medicare beneficiaries, according to a first-of-its-kind study published Friday in JAMA Network Open.